ASH HIGHLIGHTS 2024 – LYMPHOMA ROUNDTABLE DISCUSSIONS: Results from a Phase 3 Study (inMIND)
Explore more from your favourite experts – click their name to access their entire library of content.
Chair
Speaker
This program has been made possible through unrestricted support from BeiGene, Eli Lilly & Pfizer
